SI2276725T1 - Novi rutenijevi kompleksi kot katalizatorji za metatezne reakcije - Google Patents

Novi rutenijevi kompleksi kot katalizatorji za metatezne reakcije

Info

Publication number
SI2276725T1
SI2276725T1 SI200930305T SI200930305T SI2276725T1 SI 2276725 T1 SI2276725 T1 SI 2276725T1 SI 200930305 T SI200930305 T SI 200930305T SI 200930305 T SI200930305 T SI 200930305T SI 2276725 T1 SI2276725 T1 SI 2276725T1
Authority
SI
Slovenia
Prior art keywords
catalysts
metathesis reactions
ruthenium complexes
new ruthenium
new
Prior art date
Application number
SI200930305T
Other languages
English (en)
Inventor
Kurt Puentener
Michelangelo Scalone
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SI2276725T1 publication Critical patent/SI2276725T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SI200930305T 2008-04-11 2009-03-30 Novi rutenijevi kompleksi kot katalizatorji za metatezne reakcije SI2276725T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08154367 2008-04-11
EP09730174A EP2276725B1 (en) 2008-04-11 2009-03-30 New ruthenium complexes as catalysts for metathesis reactions
PCT/EP2009/053711 WO2009124853A1 (en) 2008-04-11 2009-03-30 New ruthenium complexes as catalysts for metathesis reactions

Publications (1)

Publication Number Publication Date
SI2276725T1 true SI2276725T1 (sl) 2012-09-28

Family

ID=40578497

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930305T SI2276725T1 (sl) 2008-04-11 2009-03-30 Novi rutenijevi kompleksi kot katalizatorji za metatezne reakcije

Country Status (15)

Country Link
US (1) US7939668B2 (sl)
EP (1) EP2276725B1 (sl)
JP (1) JP5531008B2 (sl)
KR (1) KR101216900B1 (sl)
CN (1) CN101970396B (sl)
AU (1) AU2009235569B2 (sl)
BR (1) BRPI0909205A2 (sl)
CA (1) CA2719531C (sl)
DK (1) DK2276725T3 (sl)
ES (1) ES2388994T3 (sl)
IL (1) IL208034A (sl)
MX (1) MX2010010660A (sl)
PL (1) PL2276725T3 (sl)
SI (1) SI2276725T1 (sl)
WO (1) WO2009124853A1 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009249443A1 (en) 2008-04-15 2009-11-26 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis C virus replication
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
CN102421786B (zh) * 2009-05-07 2016-01-20 弗·哈夫曼-拉罗切有限公司 钌易位复合催化剂的制备方法
WO2011079439A1 (en) * 2009-12-30 2011-07-07 Zannan Scitech Co., Ltd. Highly active metathesis catalysts selective for romp and rcm reactions
US8592618B2 (en) * 2010-01-08 2013-11-26 Zannan Scitech Co., Ltd. Highly active metathesis catalysts selective for ROMP and RCM reactions
US20130204026A1 (en) 2010-03-24 2013-08-08 Materia, Inc. Method for in-situ formation of metathesis catalysts
US8633280B2 (en) * 2011-03-30 2014-01-21 Zannan Scitech Co., Ltd Methods of modifying polymers with highly active and selective metathesis catalysts
EP2721027B1 (en) * 2011-06-03 2017-05-31 Massachusetts Institute of Technology Z-selective ring-closing metathesis reactions
PL220408B1 (pl) * 2011-09-26 2015-10-30 Inst Chemii Organicznej Polskiej Akademii Nauk Kompleks rutentu, sposób jego wytwarzania oraz zastosowanie
EP2826802B1 (en) 2012-03-16 2021-03-10 Zeon Corporation Method for producing ring-opening metathesis polymer hydride, and resin composition
HUE028176T2 (en) * 2012-06-29 2016-12-28 Apeiron Synthesis Sa Metal complexes, their use, and methods for performing metathesis reactions
CN107233920A (zh) * 2016-03-29 2017-10-10 上海东杰高分子材料有限公司 一种钌络合物催化剂
CN106939026B (zh) * 2017-03-09 2020-03-20 上海克琴科技有限公司 一种钌金属烯烃复分解催化剂的制备及其应用
CN109280074A (zh) * 2017-07-20 2019-01-29 歌礼药业（浙江）有限公司 丹诺瑞韦钠晶体及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2811507A (en) * 1954-10-20 1957-10-29 Koppers Co Inc Alkenylaryloxyacetamides
US5936100A (en) * 1996-12-16 1999-08-10 Studiengesellschaft Kohle Mbh Synthesis of functionalized macrocycles by ring closing metathesis
EP0921129A1 (en) * 1997-12-03 1999-06-09 Studiengesellschaft Kohle mbH Highly active cationic ruthenium and osmium complexes for olefin metathesis reactions
WO2004089974A1 (en) * 2003-04-10 2004-10-21 Boehringer Ingelheim International Gmbh Process for the preparation of macrocyclic compounds by ruthenium complex catalysed metathesis reaction
WO2004094452A2 (en) 2003-04-16 2004-11-04 Bristol-Myers Squibb Company Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
DE10335416A1 (de) * 2003-08-02 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Metathesekatalysatoren
RS20110578A3 (en) 2003-10-14 2016-02-29 F. Hoffmann-La Roche Ltd MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULPHONAMIDES AS HCV REPLICATION INHIBITORS
US7491794B2 (en) 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
AP2006003763A0 (en) * 2004-03-30 2006-10-31 Intermune Inc Macrocyclic compounds as inhibitors of viral replication
EP1794179A1 (en) * 2004-09-17 2007-06-13 Boehringer Ingelheim International Gmbh Ring-closing metathesis process in supercritical fluid
CN102816170A (zh) 2005-07-25 2012-12-12 因特蒙公司 C型肝炎病毒复制的新颖大环抑制剂
DE102006044699A1 (de) * 2006-09-22 2008-04-03 Bayerische Motoren Werke Ag Tragrohr einer Instrumententafel eines Kraftfahrzeugs

Also Published As

Publication number Publication date
KR101216900B1 (ko) 2012-12-28
CN101970396A (zh) 2011-02-09
AU2009235569B2 (en) 2012-03-29
DK2276725T3 (da) 2012-08-20
US7939668B2 (en) 2011-05-10
ES2388994T3 (es) 2012-10-22
CA2719531C (en) 2013-03-19
CN101970396B (zh) 2014-06-18
EP2276725B1 (en) 2012-07-04
PL2276725T3 (pl) 2012-11-30
EP2276725A1 (en) 2011-01-26
WO2009124853A1 (en) 2009-10-15
KR20100127822A (ko) 2010-12-06
MX2010010660A (es) 2010-10-25
BRPI0909205A2 (pt) 2015-08-11
US20090275714A1 (en) 2009-11-05
IL208034A (en) 2014-09-30
AU2009235569A1 (en) 2009-10-15
IL208034A0 (en) 2010-12-30
JP5531008B2 (ja) 2014-06-25
CA2719531A1 (en) 2009-10-15
JP2011522778A (ja) 2011-08-04

Similar Documents

Publication Publication Date Title
IL208034A0 (en) New ruthenium complexes as catalysts for metathesis reactions
PL2066443T3 (pl) Nowe katalizatory metatezowe
EG27134A (en) Shaped heterogeneous catalysts
EP2276745A4 (en) RUTHENIUM OLEFINE METATHESIS CATALYSTS HAVING SUBSTITUTED SKELETON N-HETEROCYCLIC CARBENE LIGANDS
PL2506972T3 (pl) Nośnikowe katalizatory metatezy olefin
PL2460587T3 (pl) Rutenowy układ katalityczny do reakcji metatezy olefin
GB0816705D0 (en) Shaped heterogeneous catalysts
GB0807607D0 (en) Catalyst
AP2010005415A0 (en) Catalysts.
ZA200907931B (en) Catalysts
GB0816709D0 (en) Shaped heterogeneneous catalysts
PL2158242T3 (pl) Katalizatory stabilne w wodzie do wytwarzania poliuretanu
GB201004732D0 (en) Ruthenium complexes for use in olefin metathesis
GB0819849D0 (en) Cobalt catalyst precursor
AP3177A (en) Catalysts
ZA200907932B (en) Catalysts
EP2172267A4 (en) CATALYST FOR THE DECOMPOSITION OF HYDROCARBON
PL2151446T3 (pl) Sposób wytwarzania dwukleszczowych katalizatorów rutenowych będących zasadą Schiffa zawierających ligand typu salicylaldehydoiminowego
PL2227326T3 (pl) Kompozycja powłokowa do katalizatorów utleniania do silników Diesla
GB0819847D0 (en) Cobalt catalysts
PL2151445T3 (pl) Sposób wytwarzania dwufunkcyjnych katalizatorów rutenowych będących zasadą Schiffa zawierającą ligand typu salicyloaldiminy
GB0807904D0 (en) Oxidation reactions
GB2466629B (en) Catalytic hydrogenation
GB0822064D0 (en) Process for preparing cationic ruthenium complexes
GB0806148D0 (en) Process for preparing catalysts